9 results
COVID-19 on Lung POCUS - Day 2

Day 2 after COVID diagnosis. Less sore throat, cough &
2 after COVID diagnosis ... POCUS update: small ... lung #ultrasound #pulmonary ... #BLines #POCUS ... #Effusion
Pulmonary Pathology and Associated Lung Ultrasound Findings
Pneumothorax:
 - No lung sliding/barcode sign
 - Lung point (hard
Possible small plural effusion ... Possible bilateral effusion ... submassive PE) POCUS ... #differential #diagnosis ... #signs #Lung #POCUS
COVID-19 Findings on Lung ultrasound
 - Thickened pleural line
 - B lines (multifocal, discrete, or confluent)
Thickened pleural line ... consolidation - Pleural effusion ... patients with pulmonary ... Lung #ultrasound #POCUS ... #Diagnosis #Signs
One-page resource for Lung POCUS in COVID19:
- likely (unproven) sensitive due to peripheral distribution of lesions
resource for Lung POCUS ... CT - pleural effusions ... sick but no B-lines ... #coronavirus #pulmonary ... #ultrasound #diagnosis
Malignant Complex Pleural Effusion on Lung POCUS
You are starting your RUSH exam on febrile/hypotensive patient with
Malignant Complex ... on Lung POCUS ... Diagnosis? ... #Malignant #Complex ... #Lung #POCUS #Pulmonary
Day 10 after COVID diagnosis. Less tired, but more cough, ageusia & anosmia. No dyspnea or
10 after COVID diagnosis ... POCUS update: Right ... & focal B-lines ... lung #ultrasound #pulmonary ... #BLines #POCUS
COVID-19 on Lung POCUS

Day 4 after COVID diagnosis. More cough & tiredness (very badly), still no
COVID-19 on Lung POCUS ... 4 after COVID diagnosis ... POCUS update: Right ... lung #ultrasound #pulmonary ... #BLines #POCUS
Causes of Lactate Elevation, Lactic Acidosis - Differential Diagnosis

The most common causes of hyperlactatemia are usually:
- Differential Diagnosis ... / hypoxemia -> focus ... the patient’s complete ... laboratory or diagnostic ... output - Acute pulmonary
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Disease: • 10%-15% Pulmonary ... thickening or effusion ... , INC risk PE, Pulmonary ... phenomenon (16%) MSK ... Biologic: 2nd or 3rd line